• E-mail
• Print
• Comment
• Font Size
• Digg
• del.icio.us
• Discuss article

RxElite Announces Preferred Contract Status Awarded By National Surgical Hospitals for Their Anesthetic Gas Products

Posted on: Friday, 11 April 2008, 12:00 CDT

RxElite, Inc. (OTCBB: RXEI) is pleased to announce the contract award from National Surgical Hospitals, for their anesthetic gas products. RxElite was awarded a preferred contract listing for all classes of trade for Sojourn(TM)(Sevoflurane) and Terrell(TM)(Isoflurane). Sevoflurane is most commonly used anesthetic gas in the U.S and Isoflurane continues to hold share in the anesthetic gas market.

"We are excited to partner with NSH. The agreement will yield significant cost saving to NSH members," stated Jonathan Houssian, the CEO of RxElite.

RxElite anesthetic gases are manufactured by MINRAD International, Inc. (AMEX: BUF), a leader in the innovation of anesthesia. RxElite holds the exclusive distribution rights for Minrad-produced anesthetic gases for the human market in the United States.

About RxElite, Inc.

RxElite, Inc. develops, manufactures, and markets generic prescription drug products in specialty generic markets. These markets include products in the areas of anesthesia, sterile liquid dose drugs (including respiratory inhalation drugs, ophthalmics, and injectable drugs), complex active pharmaceutical ingredients, and other specialty areas. www.RxElite.com

About MINRAD, International, Inc.

MINRAD International, Inc. is an interventional pain management company with real-time image guidance and anesthesia and analgesia product lines, and also manufactures and markets generic inhalation anesthetics for use in connection with human and veterinary surgical procedures. The company is developing a drug/drug delivery system for conscious sedation, which, similar to nitrous oxide in dental surgery, provides a patient with pain relief without loss of consciousness. www.minrad.com

About National Surgical Hospitals

National Surgical Hospitals owns, operates, and develops surgical hospitals and surgery centers in partnership with local physicians. It operates 11 surgical hospitals in Arizona, Idaho, Michigan, New Mexico, North Carolina, Texas, Utah, and Wisconsin, with additional facilities scheduled to open in the next 12 months in California, Colorado, and Wyoming. It also operates seven orthopedic-focused surgery centers in Arizona, California, Michigan, and Texas. More information about NSH's innovative way to deliver high-quality surgical care is available at http://www.nshinc.com.

Safe Harbor Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 involving known and unknown risks, delays, and uncertainties that may cause our actual results or performance to differ materially from those expressed or implied by these forward-looking statements. These risks, delays, and uncertainties include, but are not limited to: risks associated with the uncertainty of future financial results, our reliance on our sole supplier, the limited diversification of our product offerings, additional financing requirements, development of new products, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. The Company undertakes no obligation to update any forward-looking statements.

 For more information:  Corporate Information Ph: (208) 288-5550 Toll Free: (800) 414-1901 Fax: (208) 288-1191  Investor Relations Ric Tener Ph: (208) 288-5550 Fax: (208) 288-1191 Email: Email Contact

SOURCE: RXELITE, Inc.

Source: MARKET WIRE

More News in this Category